Sun Pharma receives OAI status from USFDA for Dadra facility
Mumbai: Sun Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has determined the inspection classification status of the Company’s Dadra facility as Official Action Indicated (OAI). US FDA conducted an inspection at Company’s facility from December 4, 2023 to December 15, 2023. According to USFDA, OAI means regulatory and/or administrative […]